BIOC's logo.
Ticker Symbol: BIOC

Biocept Inc

$3.89 - 05-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001044378

Company Profile

biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated dna , both in circulating tumor cells (ctcs) and in plasma (cell free circulating tumor dna). our mission is to improve outcomes for cancer patients by advancing oncology diagnostics. we utilize patented and innovative technologies to deliver clinically relevant oncology diagnostics to physicians by providing advanced prognostic and predictive assessments for guiding the course of treating patients. additionally, we offer services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies, and clinical trial support. our strategic focus is to promote our unique targeted selector™ technology to the oncology community. our target selector technology has demonstrated that it can consistently capture extremely rare cells which may be present in only 1 of every 50-100 billion blood cells. examples of these rare cells ar

Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Standard Industrial Classification Code (SIC code): 8071
Address: 5810 Nancy Ridge Dr
CEO: Michael Nall
Tags:
  • Health Technology
  • Biotechnology
  • Commercial Services
  • Miscellaneous Commercial Services
  • Health Services
  • Medical/Nursing Services
  • Health Care and Social Assistance
  • Medical Laboratories

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.56
Change: -$0.11 ( -16.82%)
Days Range: $0.51 - $0.63
Beta: 12.52
52wk. High: $13.43
52wk. Low: $0.21
Ytd. Change -10.11%
50 Day Moving Average: $1.14
200 Day Moving Average: $1.26
Shares Outstanding: 2626026

Valuation

Market Cap: 148.5M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A